Sign Up Today and Learn More About MBX Biosciences Stock
Invest in or calculate the value of your shares in MBX Biosciences or other pre-IPO companies through EquityZen's platform.
MBX Biosciences Stock (MBBI)
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
About MBX Biosciences Stock
Founded
2019
Headquarters
Carmel, IN, US
Industries
Software, Artificial Intelligence, Data and Analytics
MBX Biosciences Press Mentions
Stay in the know about the latest news on MBX Biosciences
MBX Biosciences files intention to go public
insideindianabusiness • Aug 27, 2024
MBX Biosciences’ $63.5 Million Series C Financing Round
globallegalchronicle • Aug 14, 2024
MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism
morningstar • Aug 12, 2024
The Week’s 10 Biggest Funding Rounds: Anduril Industries Raises Big For Defense
news • Aug 09, 2024
MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
finance • Aug 03, 2024
MBX Biosciences Management
Leadership team at MBX Biosciences
Board Member
Tiba Aynechi
Vice President, Product Development
Greg Davis
Join now and verify your accreditation status to gain access to:
- MBX Biosciences current valuation
- MBX Biosciences stock price
- Available deals in MBX Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in MBX Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like MBX Biosciences through EquityZen funds. These investments are made available by existing MBX Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell MBX Biosciences stock?
Shareholders can sell their MBX Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
